Across TCGA pan-cancer cohorts, FAM204BP RNA differs between tumor and matched normal tissue in 4 of 18 cancer types tested, making tumor–normal expression one of FAM204BP’s most consistent transcriptional readouts.
The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where FAM204BP RNA is more highly expressed in tumor relative to normal tissue. In most cancer types FAM204BP is over-expressed in tumor.
HNSC, COAD, and LUAD are the cancer types where FAM204BP tumor–normal differential expression is most reproducible.
RNA tumor vs normal associations by lineage
Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in FAM204BP RNA (log2); positive values indicate higher expression in tumor. p-values are from the differential-expression test.